0
Deep & Emerging Tech·July 17, 2026·1 min read

Kalshi is offering wagers on the outcomes of late-stage clinical drug trials and regulatory decisions, launching a pilot of 13 new biotech contracts

Share

Prediction markets on late-stage trials and FDA decisions turn biotech milestones into tradable signals—drug developers and funds now get a real-time, crowd-priced read on regulatory odds. Operators in pharma and biotech should expect their timelines and disclosures to be interpreted—and front-run—through this new market lens.